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Abstract  
Objective: The aim of this study was to investigate the provision of community pharmacy services to children and young people with a 
focus on advanced services such as medicines use review. Perceptions and experiences of community pharmacists, pharmacy staff, 
young people and their parents or carers on the provision of such services were also explored.  
Methods: Four different cross-sectional, self-administered questionnaires were distributed in parallel to pharmacists, pharmacy staff 
members, children and young people and parents in the United Kingdom.  
Results: An outline of pharmacist’s current involvement with children and young people was provided by 92 pharmacists. A different 
group of 38 community pharmacists and 40 non-pharmacist members of pharmacy staff from a total of 46 pharmacies provided 
information and views on the conduct of Medicines use review with children and young people. Experiences of advanced pharmacy 
service provision were collected from 51 children and young people and 18 parents. Most pharmacists offered public health advice to 
children and young people (73/92; 79.3%) and even more (83/92; 90.2%) reported that they often interacted with children and young 
people with long-term condition. Despite their high levels of interaction, and a majority opinion that medicines use reviews could 
benefit children (35/38; 92.1%), the number of pharmacies reporting to have conducted medicines use reviews with children was low 
(5/41). Pharmacists perceived the main barriers to recruitment as consent (17/29; 58.6%), guideline ambiguity (14/29; 48.3%) and 
training (13/29; 44.8%). A considerable proportion pharmacists (12/29; 41.4%) and other personnel (14/33; 42.4%) working in 
community pharmacies were unaware that children were potentially eligible for medicines use reviews. Only 29.4% of the 51 children 
and young people participants had received advice about their long-term condition from a pharmacist and the majority (46/51; 90.2%) 
had not taken part in an advanced service focused on adherence.  
Conclusions: While general engagement with children and young people appears high from the pharmacist’s perspective, advice 
specific to children and young people with long-term conditions and the provision of advanced services in this group remains a 
challenge. 
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INTRODUCTION 
The scope of practice for pharmacists across the United 
Kingdom (UK) is widening, with pharmacists in the 
community now offer healthcare services that far exceed 
the traditional process of dispensing medicines. Community 
pharmacies operate under a contract with the National 
Health Service (NHS). In 2005, a change to the NHS 
Community Pharmacy Contractual Framework (CPCF) in 
England and Wales introduced three tiers of 
pharmaceutical services (essential, advanced, and 
enhanced).
1
 The aim was to reward high-quality services 
and utilise the skills of pharmacists and pharmacy staff. All 
NHS pharmacies must deliver essential services (e.g., 
dispensing of medicines and promotion of healthy 
lifestyles) but can choose whether they provide advanced 
or enhanced services. Enhanced services are locally 
commissioned according to local need (e.g., palliative care 
support, care home support) whereas, advanced services 
may be offered nationally. There are currently six advanced 
services, two of which, the New Medicines Service (NMS) 
and Medicines Use Review (MUR), have a shared aim to 
improve and promote adherence as part of a patient-
centred consultation with a pharmacist. Community 
pharmacies are remunerated GBP 28 per MUR conducted 
and have, until recently, been capped at a maximum of 400 
per annual claim.
1
 The choice of patient to approach for 
recruitment to MUR is at the discretion of the community 
pharmacist. However, to achieve payment, 70% must fall 
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into one or more of the national target patient groups: high 
risk medicines; recently discharged from hospital with 
changes to their medicines; respiratory disease; and 
cardiovascular disease.
2
 Providing advanced services, such 
as MUR, to young people is an ideal opportunity for 
pharmacists to improve health outcomes, reduce costs to 
the NHS, such as medicines waste at an early stage.
1,2
 
Older adults are the established focus for pharmacy 
services. However, children and young people (CYP) make 
up more than 17% of the UK population which is similar in 
proportion to those aged over 65 years.
3
 In the 11-15 year-
old age group alone, approximately one in four report that 
they have a long-term condition (LTC).
4
 Common 
conditions, several of which fall within the MUR national 
target groups, include asthma, diabetes, epilepsy, arthritis 
and mental health. Rates of medicine nonadherence in 
people with LTCs are commonly reported to average at 
about 50% whereas for children the average increases to 
around 60%, and for adolescents can be as high as 70%.
5-8
 
MURs may be offered free of charge to any patient, be they 
adult (>18 years), child (<18 years) or young person (10-24 
years), prescribed one or more medicines. Prioritising the 
health of CYP, especially during transition to adult 
independence, could be beneficial to their health outcomes 
later in life. Also it is important that CYP have the 
knowledge about their medicines to ensure safe usage of 
medications. Despite their potential, MURs have not been 
evaluated for CYP specifically and data on advanced 
pharmacy services uptake by age is not reported.
9-11
  
The aim of this study was to investigate the provision of 
community pharmacy services to CYP with a focus on 
advanced services such as MUR. Perceptions and 
experiences of community pharmacists, pharmacy staff, 
CYP and their parents or carers on the provision of 
advanced services to CYP were also explored.  
 
METHODS 
Four cross-sectional self- administered questionnaires were 
distributed to UK based pharmacists, pharmacy staff 
members, CYP and parents of CYP between September and 
December 2017 (Online appendix). Study approval was 
obtained from the School of Pharmacy, University of 
Birmingham Research Ethics Sub-Committee. Willingness to 
participate was confirmed; the right to withdraw at any 
stage and maintenance of confidentiality and anonymity 
was explained to all participants prior to completion of 
each questionnaire. Participants signed an informed 
consent to take part in the study.  
Questionnaire development and distribution  
Two different questionnaires were developed for 
pharmacists, one for community pharmacy staff and one 
for CYP and the parents of CYP. The questionnaires were 
developed by the research team and informed by published 
literature addressing pharmaceutical care to CYP and 
pharmacist roles in supporting CYP. Questionnaires 
contained a series of open, closed, multiple-choice 
questions and Likert scale responses. Questionnaires were 
subject to academic review, piloted on a subset of the 
target audience and revised accordingly prior to 
distribution.  
Pharmacist questionnaires  
To minimise bias, pharmacists who took part in the first 
questionnaire did not take part in the second 
questionnaire, and vice versa.  
Questionnaire 1 focused on obtaining a snapshot of current 
service provision of pharmacists to CYP, and consisted of 21 
questions to collect demographic data and information 
about pharmaceutical care and pharmacy services offered 
to CYP, the participant’s role and current involvement. 
Pharmacists were recruited by online survey link 
dissemination via a UK-wide independent prescriber 
newsletter and hard-copy distribution by researchers 
visiting local community pharmacies. While no restriction 
was placed on the participant’s area of practice, the main 
channels of distribution targeted primary care and 
community-based pharmacists.  
Questionnaire 2 focussed on collection of data relating to 
advanced service provision to children (<18 years). It 
comprised 9 questions to collect pharmacy locations and 
annual figures (period covered 1st April 2016 to 31st March 
2017) for the number of MURs conducted with children in 
community pharmacies and, explore pharmacist 
experiences and challenges with MUR service provision for 
children. Convenience sampling was used to target 46 
community pharmacies for recruitment of one pharmacist 
per pharmacy to the study across the West Midlands. Hard 
copies of questionnaires were distributed during personal 
visits to community pharmacies.  
Pharmacy staff questionnaires  
Pharmacy staff were included in the study if they had 
potential involvement in the recruitment process for 
pharmacy services such as MURs. This questionnaire 
(questionnaire 3) included 9 questions to collect pharmacy 
locations and annual figures (period covered 1
st
 April 2016 
to 31
st
 March 2017) for the number of MURs conducted 
with children in community pharmacies and, explore the 
community pharmacy staff role, experiences and 
challenges of recruitment of children for MURs. Pharmacy 
staff were recruited at the same time as pharmacists for 
the second questionnaire (described above) during the 
same researcher visit. A maximum of one member of non-
pharmacist staff per pharmacy was recruited and hard 
copies of the questionnaire were used to collect responses.  
Children, young people and parents’ questionnaire  
Questionnaire 4 included a series of 20 questions and 
comprising two parts; one part for completion by CYP with 
long-term conditions and the second for completion by 
parents. Questions revolved around the long-term 
condition(s), number and frequency of medicines, and 
experiences of community pharmacy involvement 
healthcare provision.  
CYP and parents were targeted for recruitment through 
primary and secondary schools, a university, social media 
and two community pharmacies. Eight primary and four 
secondary schools within the East and West Midlands were 
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approached to facilitate recruitment to the study. 
Participating schools distributed an online link to students 
and parents via a weekly newsletter. Undergraduate 
students from the researcher’s university were sent a link 
to the online questionnaire and asked to share. In addition, 
with the agreement of the community pharmacy 
proprietors, researchers based themselves in two 
community pharmacies for one day to recruit participants.  
The four questionnaires were distributed by convenience 
sampling, therefore a sample size calculation was not 
conducted.  
Data analysis  
For this study we used the WHO criteria, amended 
according to UK national law, to define the age ranges of 
adults (>18 years), children (<18 years), adolescents (10-19 
years) and young people (10-24 years). Multiple choice 
question and Likert scale data were analyzed using SPSS 
v24 (IBM Corp. in Armonk, NY, USA). Free-text responses to 
open-ended questions were categorized and quantified. 
The data gathered from questionnaire 4 from both CYP and 
parents/carers was combined for analysis of demographic 
information and prescription collection behaviour. CYP and 
parent feelings about their knowledge of their/their child’s 
condition and its management was dichotomised into 
enough and not enough to facilitate analysis. Whether CYP 
forgot to take their medicines was dichotomised into yes 
and no in recognition that this question represented a 
partial indicator of adherence rather than a full validated 
measure.  
The main study outcomes included: current pharmacy 
services, pharmacy services uptake by CYP, pharmacy staff 
recruitment into services, experience of CYP with LTCs and 
their parents with pharmacy services.  
Inclusion criteria in this study: pharmacists working in 
primary care both at community pharmacies and general 
practice; pharmacy staff working at community pharmacies 
and involved in the recruitment process for pharmacy 
services; CYP people with LTCs and parents of CYP with 
LTCs. 
 
RESULTS  
A total 92 pharmacists completed questionnaire 1 
investigating current pharmacist roles with CYP. A response 
rate could not be generated due to the nature of 
recruitment. Pharmacists responded from all areas of the 
UK, the main proportion being from the West Midlands. It 
is notable that most respondents were independent 
prescribers with the main area of practice primary care. 
Demographic details are shown in Table 1.  
Of the 46 pharmacies approached for recruitment to 
questionnaire 2, 38 pharmacists and 40 non-pharmacist 
members of pharmacy staff responded. Most respondents 
were from medium chain pharmacies in high street or town 
center locations. Demographic details are shown in Table 2.  
One primary school of the 12 schools approached, 
distributed questionnaire 4 as hard-copies and online links 
to the parents or carers of 400 students. Due to the online 
nature of distribution via this and other routes, the number 
of participants from different recruitment sources and 
response rates could not be determined. There were a total 
of 78 responses to the online questionnaire of which 27 
were excluded for nonsensical answers or for not meeting 
inclusion criteria. The age (mean 20.2 years, median 21 
years, range 7 to 24 years) of the CYP respondents in this 
study suggests that most were recruited from the 
university student population. A total of 18 parents or 
carers of CYP with long-term conditions participated in this 
Table 1. Demographic details of pharmacist respondents to 
questionnaire 1 
Pharmacist respondents N (%) 
Geographical area of practice in the UK 
(n=92) 
 
East Midlands 8 (8.6) 
London 16 (17.3) 
North East 6 (6.5) 
North West 16 (17.3) 
West Midlands 21 (22.8) 
South East 8 (8.6) 
South West 5 (5.4) 
Northern Ireland 4 (4.3) 
Scotland 4 (4.3) 
Wales 4 (4.3) 
Prescribing qualification status (n=92)  
Non-prescriber 13 (14.1) 
Independent prescriber 79 (85.9) 
Main area of practice (n=92)  
Community pharmacy 34 (36.9) 
GP surgery 58 (63.0) 
Table 2. Demographic details of community pharmacy staff 
respondents to questionnaire 2 and 3 
Pharmacist respondents Number (%) 
Location of pharmacy (n=38)   
High street 11 (28.9) 
  Town or city center  10 (26.3) 
  Within a GP practice  2 (5.3) 
  Out of town shopping center  9 (23.7) 
  Supermarket  2 (5.3) 
  Village  3 (7.9) 
  Other  1 (2.6) 
Type of pharmacy (n=38)   
Single independent 2 (5.3) 
  Small chain (2-10 stores)  4 (10.6) 
  Medium chain (11-99 stores)  20 (52.6) 
  Large chain (≥100 stores)  12 (31.6) 
 
Non-pharmacist staff respondents Number (%) 
Location of pharmacy (n=40)     
High street 11 (27.5) 
  Town or city center  12 (30.0) 
  Within a GP practice  2 (5.0) 
  Out of town shopping center  8 (20.0) 
  Supermarket  2 (5.0) 
  Village  5 (12.5) 
  Other  0 (0) 
Type of pharmacy (n=39)     
Single independent 1 (2.6) 
  Small chain (2-10 stores)  3 (7.7) 
  Medium chain (11-99 stores)  23 (59.0) 
  Large chain (>100 stores)  12 (30.8) 
Job title (n=39)     
Dispenser 29 (74.4) 
  Healthcare assistant/counter assistant  4 (10.3) 
  Accuracy checking technician  3 (7.7) 
  Pharmacy technician  2 (5.1) 
  Pre-registration pharmacist  1 (2.6) 
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study. The age of the CYP they provided information about 
was broader (mean 10.2 years, median 9 years, range 2 to 
22 years). Table 3 shows the characteristics of CYP 
participants combined with the CYP information provided 
by parents and carers.  
The majority of pharmacists (83/92; 90.2%) reported that 
they often interacted with CYP with LTCs. The most 
common conditions that they encountered were asthma 
(72/92; 78.2%), mental health (47/92; 51.1%), allergies 
(45/92 48.9%), diabetes (40/92; 43.4%) and epilepsy 
(36/92; 39.1%). Regarding general promotion of healthy 
lifestyles specifically to CYP, most pharmacists (73/92; 
79.3%), reported involvement in public health advice 
provision. Advice offered ranged from that demanded as an 
essential service by the NHS CPCF (e.g. smoking and weight 
management) to enhanced service provision (e.g. 
vaccination) and beyond, to advice on alcohol misuse, 
sexual health and mental health. Despite the high 
proportion of pharmacists offering such advice to CYP, 
approximately two-thirds (62/92; 67.3%) felt that they did 
not have enough support in its provision and more than 
three-quarters (71/92; 77.2%) wanted additional training. 
Few pharmacists (13/92; 14.1%) linked to local educational 
establishments (e.g. schools, colleges, universities) or social 
care services for CYP in their daily practice.  
Participants comprised of 38 pharmacists (response rate 
82.6%) and 40 pharmacy staff (response rate 87.0%) were 
recruited from 41 of the 46 pharmacies visited resulting in 
41 annual MUR provision data sets. In the year from 1 April 
2016 to 31 March 2017, a total of 40 MURs were conducted 
with children (<18 years) in only five of 41 community 
pharmacies. The children recruited for all of these MURs 
fell into one of two national target groups; patients taking 
high risk medicines or patients with respiratory disease. 
The mean number of all MURs conducted per pharmacy in 
this period was 294.9 (SD 134.2).  
In the 36 pharmacies where MURs had only been 
conducted with adults, pharmacists and pharmacy staff 
were asked to select potential reasons for not recruiting 
children to the process. Figure 1 shows the reasons 
selected by both pharmacists and pharmacy staff. For 
pharmacists, i.e., those responsible for obtaining consent 
and conducting MURs, consent was the most popular 
reason chosen (17/29; 58.6%). Lack of guideline clarity 
(14/29; 48.3%) and training (13/29; 44.8%) were also 
identified as an issue. Interestingly, a large proportion of 
both pharmacists (12/29; 41.4%) and pharmacy staff 
(14/33; 42.4%) did not realise that MURs could be 
conducted with children. In addition, many of the 
pharmacy staff who may be involved in recruitment for 
Table 3. Demographic details for CYP from responses to 
questionnaire 4 CYP  
 N (%) 
Gender (n=69)   
  Female  46 (66.7) 
  Male  23 (33.3) 
CYP long-term condition (n=69)   
  Skin  19 (27.5) 
  Respiratory  20 (29.0) 
  Gastrointestinal  3 (4.3) 
  Mental Health  20 (29.0) 
  Endocrine  7 (10.1) 
  Cardiovascular  1 (1.4) 
  Allergy  5 (7.2) 
  Other  6 (8.7) 
No. of long term conditions per CYP (n=69)   
  1  58 (84.1) 
  2  10 (14.5) 
  >2  1 (1.4) 
No. of different medicines prescribed (n=69)   
  0  2 (2.9) 
  1  26 (37.7) 
  2  22 (31.9) 
  3  10 (14.5) 
  4 or more  9 (13.0) 
Frequency of medicine administration (n=69)   
  Less than once a day  14 (20.3) 
  Daily, once a day  28 (40.6) 
  Daily, twice a day or more  27 (39.1) 
Figure 1. Reasons selected by pharmacists and pharmacy staff for not having recruited children for MURs  
*Different reasons presented according to role in the pharmacy.  
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MURs responded that children were not the target for 
MURs.  
Despite the low numbers conducted the majority of 
pharmacists (35/38; 92.1%) were of the opinion that MURs 
could be of benefit to children. A common theme identified 
in additional free-text responses was the importance of 
improving knowledge and understanding for older children. 
When asked about the challenges of conducting MURs with 
children, three main themes emerged and had a particular 
focus on younger children; assessing competency and 
understanding; obtaining consent and absence of the child.  
Although few participants reported themselves as having 
diabetes, other LTCs were generally as expected for CYP 
with respiratory (asthma) and mental health issues the 
most common. As anticipated for this population the 
majority reported only one LTC. Where more than one LTC 
was reported, the combinations were mainly associated 
conditions (e.g., asthma and eczema; depression and 
anxiety). All CYP reporting to have respiratory disease, 
named their condition as asthma. All CYP reporting a skin 
condition in this sample named their condition as eczema. 
Given the prevalence of asthma (20/69; 29.0%) and eczema 
(19/69; 27.5%), it is unsurprising that more than half 
(41/69; 59.4%) were prescribed two or more medicines and 
the frequency of administration for most was at least once 
a day (Table 3).  
The conditions above were grouped and classified 
according to WHO ICD 11 classification of disease.
12
 The 
diseases that fell under the classifications included asthma 
(Diseases of the respiratory system); mental health 
depression and anxiety (Mental, behavioural or 
neurodevelopmental disorders); diabetes (Endocrine, 
nutritional or metabolic diseases); epilepsy ( Diseases of the 
nervous system), skin condition (Dermatitis and Eczema) 
the ICD 11 specific codes are not shown here as such data 
was not collected. 
Most CYP (53/66; 80.3%) felt they had enough knowledge 
about their condition and its treatment in order to manage 
it effectively. When asked what healthcare professionals 
had provided them with information about their LTC and 
given freedom to choose multiple options, only 29.4% 
(15/51) selected pharmacist. Responses were similar for 
parents and carers with 83.3% (15/18) feeling that they had 
enough knowledge about their child’s condition and its 
management and with 27.8% (5/18) getting information 
from a pharmacist. One of the aims of advanced pharmacy 
services such as MUR is to improve adherence. More than 
half of CYP (31/51; 60.8%) and their parents or carers 
(9/18; 50.0%) recognised non-adherence, due to 
forgetfulness, as an issue in their situation. Yet, the 
majority of CYP (46/51; 90.2%) and parents/carers (17/18; 
94.4%) reported they/their children had not taken part in 
these advanced services even though almost two-thirds 
(45/68; 66.2%) reported that they tended to use the same 
pharmacy for supply of prescription medicines. 
 
DISCUSSION 
Pharmacists encounter CYP often but the number of MURs 
conducted with CYP is low. Despite the prevalence of 
childhood LTCs and pharmacists self-identifying that their 
interactions are with CYP with the most common LTCs (e.g., 
asthma), many community pharmacists and pharmacy staff 
did not realise that MURs could be conducted with 
children. It is possible, therefore that pharmacists may not 
have considered the national MUR target groups to include 
children. Those pharmacists working in a pharmacy that 
had not conducted MURs with children identified consent 
issues as the main barrier to recruitment followed by lack 
of guideline clarity and training. For the few 
pharmacists/pharmacies that did conduct MURs with 
patients under 18 years, all of them fell into two of the four 
national target groups (i.e., taking high risk medicines or 
respiratory disease).  
For those community pharmacists offering public heath 
advice and MUR to CYP, they reported a need for additional 
support and training. When coupled with a lack of links to 
CYP support networks (e.g., schools, universities), and 
issues of assessing competence and obtaining consent, 
these are all likely to contribute to the minimal pharmacy 
service provision and pharmacist advice reported by CYP.  
Strengths and limitations  
There is limited research published on community 
pharmacist engagement with young people through the 
provision of MURs to children in the UK.
13,14
 This study adds 
to the minimal literature on the provision of advanced 
services, in particular MUR, for children and starts to 
provide insight into CYP experiences of adherence-focussed 
advanced services. All questionnaires contained closed 
questions with the opportunity for respondents to add 
extra information as free-text. The four questionnaires 
were distributed by three different researchers and used 
varying methods of delivery; hence there was uneven 
distribution across the UK and the majority of respondents 
were from a Midlands location. Due to the distribution 
methods used, response rates could not be obtained for 
two (questionnaire 1 and 2) of the four questionnaires.  
Results of this study were triangulated by gathering 
information from different pharmacists, pharmacy staff CYP 
and parents. Data gathered about pharmacist’s general 
experience of dealing with CYP and the services offered 
from questionnaire 1 included a high proportion of 
independent prescriber pharmacists. While this was useful 
to identify emerging roles of primary care pharmacists and 
the advice they offered, it has limited relation to 
community pharmacy services. Due to the small numbers 
of participants no firm conclusions could be drawn 
however, when questionnaire 1 is considered in 
combination with questionnaire 2, whose participants were 
all community pharmacists, and questionnaires 3 and 4 
where the participants were all users of community 
pharmacy services, the data provides an indicative 
snapshot of the current interactions of pharmacists with 
CYP and conduct of MURs with children which adds to 
published literature.  
Part of the aim of this study was to investigate the 
community pharmacist’s current role with and services 
offered to CYP, yet the ages of this group ranges from 2 to 
24 years representing a broad array of development, 
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understanding, and competence. To what extent 
pharmacist and pharmacy staff participants were focussing 
on lower and upper extremes of this age range when 
responding to questionnaires cannot be determined. MUR 
data was collected for those of 18 years and younger (i.e., 
the definition of a child in the UK) whereas the majority of 
questionnaire 3 respondents fell within the definition of an 
adult (i.e., 18 years and older) but according to WHO 
criteria still met the definition of a young person (10-24 
years). Despite the discrepancies in age ranges considered 
between the different aspects of this study, the 
experiences of the CYP involved in questionnaire 3 and 4 
align with the small numbers of MURs with CYP reported in 
questionnaire 2. All questionnaires had small sample sizes. 
In addition, the respondents to questionnaire 3 were likely 
to be medical, and pharmacy undergraduates where prior 
knowledge or interest might have biased their interactions 
with and experience of community pharmacy and the 
services/advice offered.  
Implications for practice  
The conventional focus of much community pharmacy 
activity is directed at adults and the ailments that come 
with aging.
15
 Pharmacy schemes targeting the young tend 
to revolve around public health and lifestyle rather than 
long-term disease and its management.
16
 For this reason, 
and a general perception that young people are rarely ill, 
CYP are at risk of being overlooked for advanced pharmacy 
services. In line with previous UK-based studies, this 
research shows that it is uncommon for pharmacists to 
conduct MURs with CYP.
13,14
 Previous research has found 
that pharmacists and community pharmacy staff did not 
feel it appropriate to offer adult focussed services to those 
under 16 years of age.
17
 In contrast, a high proportion of 
community pharmacists and staff in this study were 
unaware that their advanced services could be offered to 
children. Interestingly, previous research has shown a lack 
of public awareness of pharmacy services as potentially 
limiting the optimal use of community pharmacies.
18,19
 
Awareness, therefore is an issue that needs to be 
addressed for both pharmacists, their staff and the general 
public. This lack of awareness could be tackled by providing 
training on management of LTCs for CYP in continuous 
development sessions for pharmacists and pharmacy staff. 
Furthermore, by raising awareness in public health 
campaigns for the public regarding available pharmacy 
services. Both pharmacists and pharmacy staff in this study 
reported the need for additional training as they did not 
realise that MUR services could be provided to CYP. 
Previous studies have highlighted the importance of 
developing paediatric pharmaceutical teaching at both 
undergraduate curricula and postgraduate education 
sessions and also at the pre-registration stage for 
pharmacists.
20,21
 
The question of who may benefit most from advanced 
services such as MUR is yet to be addressed.
22
 However, 
CYP, especially those starting to take responsibility for their 
own health, may stand to benefit more than adults with the 
same condition by gaining a better understanding of the 
importance of adherence in disease management at an 
earlier stage. This research showed that where MURs were 
conducted with children, asthma was the main reason. The 
high prevalence of asthma in children (i.e. one in six 
children between 5 and 14 years) coupled with evidence 
suggesting this to be one of the few conditions where there 
is a proven benefit from MUR suggests these patients 
should be targeted for advanced adherence-focussed 
pharmacy services.
23,24
 The incidence of mental health 
issues in this study’s CYP population equalled that of 
asthma. Given the recent recognition of the mental health 
support needed for CYP there is a missed opportunity in 
terms of MUR target groups within the CYP population 
which may need to be considered within national policy.
25
  
Published literature suggests that children above the age of 
7 years generally accept advice and communicate well with 
pharmacists during counselling.
26
 Many children take 
responsibility and independently manage their medicines 
for long term conditions with minimal knowledge.
27
 
However, non-adherence is reported as higher for children 
and adolescents than in adults.
7,8
 In addition, there is 
national recognition of the gaps associated with transition 
of care from children’s to adult’s health and social care 
services.
28
 This makes advanced services specifically 
targeting adherence issues, such as NMS and MUR, 
potentially valuable in this group. Aston et al. identified 
that pharmacists perceived difficulties in taking consent as 
the most common reason for not conducting NMS or MURs 
with children.
14
 The same was true of this study where this 
perception also extended to pharmacy staff. In addition, 
pharmacists and pharmacy staff in this study perceived that 
a lack of guideline clarity was also a barrier. Guidelines 
clearly state that children are eligible if they have the 
capacity to engage in the process and able to consent.
2
 
Adolescents, in particular, are likely to understand their 
medicines, communicate at an appropriate level and 
provide consent. However, the potential subjectivity 
associated with competence assessment and consent 
could, in part, account for the feelings that guidelines and 
training are not adequate for conducting MURs with CYP. 
Further guidance on assessing competence and obtaining 
appropriate consent may be necessary for pharmacists to 
give them the confidence in performing these tasks in such 
potentially vulnerable groups 
US studies report that children either do not visit 
community pharmacies, or only accompany their parents to 
pick up their medication only 29% of the time.
26,29
 This has 
also been identified as a barrier to building long-term 
relationships and engaging with young people with LTCs in 
the UK community pharmacy setting.
30
 While many 
children with LTCs may not present to a community 
pharmacy, this study suggests that CYP and their 
parents/carers, tend to use the same pharmacy to collect 
their prescriptions. Importantly then, a community 
pharmacist is likely to remain a constant during a child’s 
development and possibly during the potentially difficult 
transition from child to adult healthcare services. Guidance 
for advanced services such, as MUR and NMS, currently 
states that they must be conducted by a pharmacist with 
the patient and not in the presence of a parent or carer. 
Removing this requirement and allowing consultations in 
the presence of parents and carers is suggested as a way to 
facilitate the transition of care and handover of 
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responsibility for medicines from parent/carer to child. This 
would, however, require some comprehensive guidance 
and for pharmacists about how to implement and gain 
consent from all parties and on how to deal with the 
complexities of the parent/carer and child relationship. In 
addition, community pharmacists would need to build the 
essential links to primary care, social care, and educational 
establishments that this study shows are currently missing 
in their daily practice.  
From the pharmacist’s perspective issues associated with 
non-adherence in a younger patient may appear more 
difficult to tackle than for older adults. Even though this 
group tends to take fewer medicines, without the 
strategies for communication and experience of dealing 
with younger patients pharmacists may feel unequipped to 
interact. This study and others focussing on adolescents 
found that pharmacists feel inadequately trained when it 
comes to dealing with young people.
31,32
 This suggests that 
pharmacists may need further experience and training in 
dealing with children, child health issues, and consent as 
part of the accreditation process for such advanced 
services. Incorporating these topics into training for 
accreditation would in turn, raise awareness that children 
may be eligible for advanced services.  
Over the next few years MURs conducted by community 
pharmacists are being phased out in the UK to be replaced 
by enhanced structured medication reviews.
33
 It is intended 
that these will be carried out by clinical pharmacists 
working within primary care networks under new GP 
contractual arrangements. Despite a new route to delivery 
by a different group of pharmacists, the findings of this 
study remain relevant. CYP with LTC require medicines 
review and, due to potentially higher non-adherence rates 
than for adults, their conduct may have a greater impact on 
longer term clinical outcomes than for adults with the same 
condition. 
 
CONCLUSIONS 
Research is needed to provide evidence for the efficacy of 
all medicine reviews which would ideally be stratified by 
age and LTC. The pharmacists conducting reviews need 
training, not only in communicating with CYP across all age 
ranges but importantly in the process of assessing 
competence and consent. 
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